webinar register page

Webinar banner
2021 Joint Pre-ECTRIMS Online workshop
Registration is free of charge, however there are limited places available.

Scientific Agenda
Day 1 - October 11th, 2021

15.00-15.10 Welcome & Opening

Session 1: Understanding Multiple Sclerosis
15.10-15.30 Emerging environmental factors triggering MS: the gut-brain axis
S. Baranzini, US

15.30-15.50 Immunosenescence and MS
A.Bar-Or, Canada

15.50-16.05 Q&A

Session 2: Treating Multiple Sclerosis
16.05-16.25 Present and future of treating relapsing MS
F.D. Lublin, US

16.25-16.45 Present and future of treating progression
G. Comi, Italy

16.45-16.55 Break

16.55-17.15 Enhancing recovery: new approaches
L. Leocani, Italy

17.15-17.35 MS and demyelinating diseases in children
B. Banwell, US

17.35-17.50 Q&A

Session 3: Monitoring Multiple Sclerosis
17.50-18.10 Updated Role of MRI in Monitoring MS
F. Barkhof, the Netherlands

18.10-18.30 Diagnosis and monitoring of cognitive functions in MS
I.K. Penner, Germany

18.30-18.45 Q&A

18.45-19.30 Panel Discussion - Lessons learned from Covid-19
C. Harris, Canada; A. Perrin-Ross, US; M.A. Robles Sanchez, Spain

19.30 End of Day 1

Day 2 - October 12th, 2021

Session 4: Patient reported outcomes: new perspectives
15.01-15.20 The PROMS initiative
P. Zaratin, Italy

15.20-15.40 Research, validation and development
P. Vermersch, France

15.40-16.0 Role in clinical management
R. McBurney, US

16.00-16.15 Q&A

16.15-16.25 Break

Session 5: MS Controversies 2021- The Future of MS Care
16.25-16.45 New evidence on the role of oligodendrocytes and OPCs in MS
C. Lubetzki, France

16.45-17.05 Moving fluid biomarkers into the clinic
M. Comabella, Sapin -J. Kuhle, Switzerland

17.05-18.00 Round Table: MS care in this and the next pandemic: transcontinental perspective
J. Correale, Argentina; A. Cross, USA; G. Giovannoni, UK

18.00-18.15 Q&A

18.15-18.30 Wrap up and closing remarks

18:30 End of the Workshop
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: EXCEMED.